Literature DB >> 8603238

Partial splenic embolization decreases the serum bilirubin level in patients with hypersplenism following the Kasai procedure for biliary atresia.

H Ando1, T Ito, M Nagaya.   

Abstract

BACKGROUND: Partial splenic embolization (PSE) has been used in the palliative treatment of adults and children with hypersplenism. However, there has been no previous report of its use in the treatment of patients with jaundice. The purpose of this study was to investigate the utility of PSE in the treatment of jaundice in patients with biliary atresia and hypersplenism. STUDY
DESIGN: Partial splenic embolization was performed in eight patients with biliary atresia and hypersplenism that developed following the Kasai procedure. Seven of them had experienced complete resolution of jaundice postoperatively, but became icteric thereafter. Jaundice remained unchanged in the initial postoperative period in the last patient but subsequently worsened. White blood cell, platelet, and red blood cell counts, hematocrit, and hemoglobin concentrations, and serum concentrations of glutamic-oxaloacetic transaminase, glutamate pyruvate transaminase, alkaline phosphatase, lactate dehydrogenase, albumin, and total bilirubin were evaluated one month before PSE and one, two, three, six, nine, 12, 18, and 24 months after PSE.
RESULTS: The total bilirubin concentration decreased in all patients after PSE from 8.6 +/-3.6 mg/dL to 3.0 +/-1.0 mg/dL. This change was noted within three months of PSE, and correlated with an increase in the red blood cell count.
CONCLUSIONS: Partial splenic embolization is a useful method for reducing serum bilirubin concentrations in patients with hypersplenism following the Kasai procedure for biliary atresia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8603238

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  3 in total

1.  Evaluation of the effect of partial splenic embolization on platelet values for liver cirrhosis patients with thrombocytopenia.

Authors:  Chi-Ming Lee; Ting-Kai Leung; Hung-Jung Wang; Wei-Hsing Lee; Li-Kuo Shen; Jean-Dean Liu; Chun-Chao Chang; Ya-Yen Chen
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

2.  Selective splenic artery embolization for the treatment of thrombocytopenia and hypersplenism in paroxysmal nocturnal hemoglobinuria.

Authors:  David J Araten; Anna Paola Iori; Karen Brown; Giovanni Fernando Torelli; Walter Barberi; Fiammetta Natalino; Maria Stefania De Propris; Corrado Girmenia; Filippo Maria Salvatori; Orly Zelig; Robin Foà; Lucio Luzzatto
Journal:  J Hematol Oncol       Date:  2014-03-27       Impact factor: 17.388

3.  <Editors' Choice> Long-term outcomes of the partial splenectomy for hypersplenism after portoenterostomy of patients with biliary atresia.

Authors:  Takahisa Tainaka; Akinari Hinoki; Yujiro Tanaka; Chiyoe Shirota; Wataru Sumida; Kazuki Yokota; Satoshi Makita; Kazuo Oshima; Hizuru Amano; Aitaro Takimoto; Yoko Kano; Hiroo Uchida
Journal:  Nagoya J Med Sci       Date:  2021-11       Impact factor: 1.131

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.